Advanced Platelet‐Rich Fibrin in Surgical Management of Medication‐Related Osteonecrosis of the Jaw: A Prospective Case Series Study
Clinical and Experimental Dental Research · 2026
DOI: 10.1002/cre2.70346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dental Research, 2026. Verfasst von Besim Hajdari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maxillofacial Surgery, Faculty of Medicine, School of Dentistry, University of Prishtina, Prishtina, Kosovo. Hauptthemen laut MEDLINE: Platelet-Rich Fibrin, Bisphosphonate-Associated Osteonecrosis of the Jaw. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Medication‐related osteonecrosis of the jaw (MRONJ) is a severe complication associated with antiresorptive or antiangiogenic therapy. Surgical debridement is the mainstay of treatment for moderate to advanced disease, while adjunctive regenerative approaches such as advanced platelet‐rich fibrin (A‐PRF) may enhance soft tissue healing. This study aimed to evaluate the clinical outcomes of A‐PRF as an adjunct to surgical management of MRONJ.
Methods
Seventeen patients diagnosed with MRONJ according to AAOMS criteria were prospectively enrolled. All patients underwent surgical removal of necrotic bone followed by placement of A‐PRF membranes and tension‐free mucosal closure. A‐PRF was prepared from autologous venous blood using a low‐speed centrifugation protocol. Mean follow‐up was 11.6 months. Treatment success was defined as complete mucosal healing without clinical signs of infection or bone exposure.
Results
The mean age was 60.2 ± 7.8 years; 70.6% were female and 70.6% had cancer‐related disease. Stage 2 MRONJ was most prevalent (58.8%). Complete mucosal healing was achieved in 13 patients (76.5%). Four patients (23.5%) showed persistent bone exposure but reported symptomatic improvement.
Conclusion
Adjunctive use of A‐PRF in MRONJ surgery was associated with favorable soft tissue healing and clinical improvement. Larger controlled studies are needed to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Maxillofacial Surgery, Faculty of Medicine, School of Dentistry, University of Prishtina, Prishtina, Kosovo.
- Department of Oral Surgery, Faculty of Medicine, School of Dentistry, University of Prishtina, Prishtina, Kosovo.
- Private Dental Clinic Ars - Medica, Prishtina, Kosovo.
- Department of Pediatrics, University Clinical Centre of Kosovo, Prishtina, Kosovo.
- Faculty of Medicine, University of Prishtina, Prishtina, Kosovo.
- Department of Prosthodontics, University Dentistry Clinical Centre of Kosovo, Prishtina, Kosovo.
ORCID-Profile: Besim Hajdari, Lavdie Leci Morina, Granit Gashi, Gloriosa Dobra, Besir Salihu, Venera Bimbashi
Zitieren
APA
Hajdari, B., Morina, L. L., Gashi, G., Dobra, G., Salihu, B., & Bimbashi, V. (2026). Advanced Platelet‐Rich Fibrin in Surgical Management of Medication‐Related Osteonecrosis of the Jaw: A Prospective Case Series Study. Clinical and Experimental Dental Research. https://doi.org/10.1002/cre2.70346
Vancouver
Hajdari B, Morina LL, Gashi G, Dobra G, Salihu B, Bimbashi V. Advanced Platelet‐Rich Fibrin in Surgical Management of Medication‐Related Osteonecrosis of the Jaw: A Prospective Case Series Study. Clinical and Experimental Dental Research. 2026. doi:10.1002/cre2.70346
BibTeX
@article{Hajdari2026,
author = {Hajdari, Besim and Morina, Lavdie Leci and Gashi, Granit and Dobra, Gloriosa and Salihu, Besir and Bimbashi, Venera},
title = {Advanced Platelet‐Rich Fibrin in Surgical Management of Medication‐Related Osteonecrosis of the Jaw: A Prospective Case Series Study},
journal = {Clinical and Experimental Dental Research},
year = {2026},
doi = {10.1002/cre2.70346}
}
EUVIMED